Episode Details

Moderna — the company that became a household name during the global pandemic — is now attacking cancer treatment with personalized mRNA technology in the form of a melanoma immunotherapy vaccine. But does their research hold up?

🎯 What You’ll Learn in This Episode:
- What Moderna’s mRNA melanoma vaccine does
- How neoantigen vaccines are created
- Why Keytruda is used in combination
- What a 49% recurrence reduction actually means
- The role of tumor heterogeneity
- Why cold vs hot tumors matter
- How tumor microenvironment impacts response
- Differences between synthetic vaccines and direct tumor immunotherapy

📍 Envita Medical Centers – Scottsdale, AZ
🌐 Learn more: www.envita.com
📞 Speak with a care coordinator: 866-830-4576

“The future of cancer care isn’t one-size-fits-all — it’s immune-informed precision.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

https://www.scirp.org/journal/paperinformation?paperid=132493